Nationwide trends in the incidence and outcome of patients with gastrointestinal stromal tumour in the imatinib era

Background The incidence, treatment and outcome of patients with newly diagnosed gastrointestinal stromal tumour (GIST) were studied in an era known for advances in diagnosis and treatment. Methods Nationwide population‐based data were retrieved from the Netherlands Cancer Registry. All patients wit...

Ausführliche Beschreibung